301234.SZ
Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd.
SZSE · C 制造业 · CN
CNY 131.77
+4.83%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 454.8M | 458.3M | 477.4M | 533.7M | 547.1M |
| Cost of Revenue | 385.7M | 391.5M | 392.5M | 420.0M | 424.4M |
| Gross Profit | 69.1M | 66.8M | 85.0M | 113.7M | 122.7M |
| Operating Expenses | |||||
| R&D Expense | 9.2M | 9.7M | 13.0M | 13.5M | 13.1M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 19.1M | 19.5M | 19.0M | 19.9M | 30.2M |
| Selling & Marketing Expense | 18.9M | 18.2M | 14.1M | 15.3M | 13.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 53.0M | 50.2M | 40.4M | 43.4M | 51.3M |
| Cost and Expenses | 438.7M | 441.7M | 432.8M | 463.3M | 475.8M |
| Operating Income (EBIT) | 25.8M | 23.5M | 46.9M | 68.5M | 62.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 25.4M | 22.9M | 46.5M | 70.9M | 73.4M |
| Income Tax Expense | 4.0M | 4.0M | 6.5M | 10.7M | 2.5M |
| Bottom Line | |||||
| Net Income | 21.3M | 18.9M | 40.0M | 60.3M | 70.9M |
| Earnings from Cont. Ops | 21.3M | 18.9M | 40.0M | 60.3M | 70.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 21.3M | 18.9M | 40.0M | 60.3M | 70.9M |
| Per Share | |||||
| Basic EPS | CN¥0.31 | CN¥0.28 | CN¥0.59 | CN¥0.89 | CN¥1.19 |
| Diluted EPS | CN¥0.31 | CN¥0.28 | CN¥0.59 | CN¥0.89 | CN¥1.19 |
| Revenue Per Share | CN¥6.69 | CN¥6.74 | CN¥7.02 | CN¥7.85 | CN¥9.20 |
| Shares | |||||
| Basic Shares Outstanding | 68.0M | 68.0M | 68.0M | 68.0M | 59.5M |
| Diluted Shares Outstanding | 68.0M | 68.0M | 68.0M | 68.0M | 59.5M |
| Profitability Metrics | |||||
| EBITDA | — | 61.8M | 85.1M | 98.8M | 84.6M |
| D&A | — | 38.3M | 38.2M | 30.3M | 22.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026